Recent Updates
Recently added Catalysts
ATHE Positive Sentiment

Application for quotation of +securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Friday

Key Takeaway: Alterity Therapeutics Limited has announced the quotation of a significant number of new securities on the ASX, including 571,428,556 fully paid ordinary shares and 190,476,123 options expiring in 2026. This follows a previous announcement regarding the securities issuance, indicating continued development and capital raising efforts by the company. The securities are being issued at a low price, which may attract more investors as the company seeks to bolster its funding for future endeavors.
Price reaction · baseline $2.13 (2024-02-01 close) · hit after-hours · 1 other ATHE headline(s) in the window, move may be shared
day 0 close · peak
-2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Alterity Therapeutics is moving forward with the quotation of a large number of securities.
  • The issuance of securities follows a previous announcement and indicates company growth.
  • The issuance price is relatively low, suggesting potential for attractive entry for investors.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Friday February 02, 2024
The +securities to be quoted are:
+Securities issued as part of a
transaction or transactions previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
ASX +security code Security description Number of +securities to be quoted Issue date
ATH ORDINARY FULLY PAID 571,428,556 02/02/2024
ATHO OPTION EXPIRING 31-AUG-2026 190,476,123 02/02/2024
Refer to next page for full details of the announcement
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of the following +securities
and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
as part of a transaction or transactions previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
Announcement Date and Time Announcement Title Selected Appendix 3B to submit quotation request
22-Nov-2023 09:55 New - Proposed issue of securities - ATH A placement or other type of issue
2.3a.2 Are there any further issues of +securities
yet to take place to complete the transaction(s) referred to in the Appendix 3B?
2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s)
referred to in the Appendix 3B
571,428,556 unlisted Short-Dated Options (each with an exercise price of A$0.007, expiring on 31 August 2024)
ASX +security code and description
ATH : ORDINARY FULLY PAID
Distribution Schedule
Provide a distribution schedule for the new +securities
according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities
held by the recipients in each category.
Number of +securities held Number of holders Total percentage of +securities held For example, to enter a value of 50% please input as 50.00
1 - 1,000 %
1,001 - 5,000 %
5,001 - 10,000 %
10,001 - 100,000 %
100,001 and over %
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
In what currency is the cash consideration being paid? What is the issue price per +security?
AUD - Australian Dollar AUD 0.00350000
Any other information the entity wishes to provide about the +securities to be quoted
Shares issued per Securities Purchase Plan result announced 2 February 2024
ASX +security code and description
ATHO : OPTION EXPIRING 31-AUG-2026
Distribution Schedule
Provide a distribution schedule for the new +securities
according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities
held by the recipients in each category.
Number of +securities held Number of holders Total percentage of +securities held For example, to enter a value of 50% please input as 50.00
1 - 1,000 %
1,001 - 5,000 %
5,001 - 10,000 %
10,001 - 100,000 %
100,001 and over %
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
Please describe the consideration being provided for
One (1) free attaching long-dated option per three (3) shares
issued under SPP per Prospectus issued 29 December 2023
Please provide an estimate (in AUD) of the value of
the consideration being provided per +security for the
+securities to be quoted
Any other information the entity wishes to provide
about the +securities to be quoted
Long-Dated Options issued per Securities Purchase Plan result
announced 2 February 2024
Following the quotation of the +securities the subject
of this application, the issued capital of the entity will comprise:
(A discrepancy in these figures compared to your own
may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)
Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 4,382,754,741
ATHO : OPTION EXPIRING 31-AUG-2026 647,618,953
Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAI : OPTION EXPIRING 31-AUG-2024 EX $0.007 1,371,428,567
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 8,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720

Frequently Asked Questions

What new securities is Alterity Therapeutics quoting?

Alterity Therapeutics is quoting 571,428,556 ordinary shares and 190,476,123 options.

When were the new securities issued?

The new securities were issued on February 2, 2024.

What is the exercise price for options expiring in 2026?

The exercise price for options expiring on August 31, 2026, is A$0.007.

Are the new securities being issued for cash?

Yes, the new securities are issued for cash at A$0.0035 each.

How many total ordinary shares are on issue?

After this issuance, there will be 4,382,754,741 ordinary shares on issue.

Last updated: Feb 2, 2024